-+ 0.00%
-+ 0.00%
-+ 0.00%
China Biopharmaceutical: Kylo-11 “LPA siRNA” released phase I clinical data at the 2026 European Society of Cardiology Annual Meeting and “The Lancet”.
Share
Listen to the news
China Biopharmaceutical: Kylo-11 “LPA siRNA” released phase I clinical data at the 2026 European Society of Cardiology Annual Meeting and “The Lancet”.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending